Want to see ATLN full AI Analyst Report?
Top Page
Atlantic International
(NASDAQ:ATLN)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.89
▼(-80.04% Downside)
Action:Reiterated
Date:07/01/26
The score is primarily held back by weak financial quality (losses, negative free cash flow, and high leverage/fragile equity history). Technicals also lean negative with the stock below longer-term moving averages. Valuation provides limited support due to losses and no dividend data, while corporate events are mixed—strategic wins and compliance progress are counterbalanced by material legal/creditor risk.
Positive Factors
Scale from Circle8 acquisition
The acquisition enlarged recurring revenue scale to >$1.1–$1.2B annualized, giving the company enterprise-level scale to pursue large bids, diversify customer mix across regions and service lines, and capture operating leverage as integrations drive margin recovery over time.
Negative Factors
High leverage vs equity
Elevated debt relative to a thin and historically volatile equity base limits financial flexibility, raises refinancing and covenant risk, and increases interest burden. This structural capital tension constrains investment, magnifies downturn sensitivity, and pressures strategic options.
Read all positive and negative factors
Positive Factors
Negative Factors
Scale from Circle8 acquisition
The acquisition enlarged recurring revenue scale to >$1.1–$1.2B annualized, giving the company enterprise-level scale to pursue large bids, diversify customer mix across regions and service lines, and capture operating leverage as integrations drive margin recovery over time.
Read all positive factors
Atlantic International (ATLN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$67.28M
Dividend YieldN/A
Average Volume (3M)364.23K
Price to Earnings (P/E)―
Beta (1Y)-0.81
Revenue Growth27.45%
EPS Growth82.80%
CountryUS
Employees300
SectorIndustrials
Sector Strength72
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)-1.32
Shares Outstanding81,293,030
10 Day Avg. Volume70,257
30 Day Avg. Volume364,234
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-2.27
Price to Sales (P/S)0.17
P/FCF Ratio-16.34
Enterprise Value/Market Cap1.96
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit2.35
Enterprise Value/Ebitda-2.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.61
Revenue Forecast (FY)$481.08M
Atlantic International Business Overview & Revenue Model
Company Description
Based in Billerica, Massachusetts, and established in 2013, Atlantic International Corp. (which operated as SeqLL Inc. until its name change in June 2024) underwent a significant corporate change on June 18, 2024, when it was acquired by Lyneer In...
How the Company Makes Money
null...
Atlantic International Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
18
Very Negative
Cash Flow
20
Very Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 435.88M | 442.61M | 401.37M | 441.54M | 425.03M |
| Gross Profit | 45.99M | 47.18M | 46.88M | 54.21M | 54.41M |
| EBITDA | -43.64M | -113.10M | 1.44M | 11.94M | 12.18M |
| Net Income | -59.43M | -135.48M | -15.25M | -3.22M | -40.80M |
Balance Sheet | |||||
| Total Assets | 113.23M | 122.75M | 126.67M | 8.41M | 10.74M |
| Cash, Cash Equivalents and Short-Term Investments | 81.13K | 678.68K | 1.35M | 6.22M | 9.95M |
| Total Debt | 87.67M | 82.72M | 142.62M | 2.93M | 1.38M |
| Total Liabilities | 145.32M | 134.77M | 166.02M | 4.05M | 2.56M |
| Stockholders Equity | -32.09M | -12.02M | -39.35M | 4.37M | 8.18M |
Cash Flow | |||||
| Free Cash Flow | -4.46M | -6.06M | -9.16M | -3.70M | -2.00M |
| Operating Cash Flow | -4.40M | -5.99M | -9.08M | -3.66M | -1.99M |
| Investing Cash Flow | -66.77K | -73.46K | -73.71K | 1.83M | -5.99M |
| Financing Cash Flow | 3.87M | 5.38M | 8.79M | -9.45M | 12.00M |
Atlantic International Technical Analysis
Negative
4.45
Price Trends
1.23
Negative
2.20
Negative
2.41
Negative
Market Momentum
-0.11
Negative
45.91
Neutral
33.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATLN, the sentiment is Negative. The current price of 4.45 is above the 20-day moving average (MA) of 0.82, above the 50-day MA of 1.23, and above the 200-day MA of 2.41, indicating a neutral trend. The MACD of -0.11 indicates Negative momentum. The RSI at 45.91 is Neutral, neither overbought nor oversold. The STOCH value of 33.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATLN.
Atlantic International Risk Analysis
Atlantic International disclosed 48 risk factors in its most recent earnings report. Atlantic International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Atlantic International Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | $284.91M | -3.70 | -46.74% | ― | 167.42% | -22.94% | |
54 Neutral | $776.53M | -9.93 | -55.89% | ― | -52.94% | 59.88% | |
50 Neutral | $109.69M | -5.04 | -113.53% | ― | 20.55% | -4.63% | |
43 Neutral | $67.28M | -0.68 | 274.33% | ― | 27.45% | 82.80% | |
43 Neutral | $98.12M | -2.61 | -164.68% | ― | 69.52% | 58.15% | |
42 Neutral | $24.48M | -0.71 | 402.97% | ― | 17.42% | 42.75% |
* Industrials Sector Average
ATLN
Atlantic International
0.83
-1.09
-56.93%
ACRS
Aclaris Therapeutics
5.56
4.10
280.82%
MDXH
MDxHealth
0.48
-1.66
-77.76%
STIM
Neuronetics
1.41
-1.96
-58.16%
XGN
Exagen
4.54
-2.42
-34.77%
PRE
Prenetics Group
16.93
8.92
111.36%
Atlantic International Corporate Events
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesRegulatory Filings and Compliance
Atlantic International Rebrands as Circle8 and Reshapes Leadership
Positive
Jul 1, 2026
On June 29, 2026, Atlantic International Corp. filed an amendment in Delaware to change its corporate name to Circle8 Group, Inc., with its Nasdaq listing expected to move from ATLN to the new ticker CIRC on July 2, 2026, while preserving all exis...
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Atlantic International Secures Key Dutch ICT Framework Deal
Positive
Jun 25, 2026
On June 23, 2026, Atlantic International announced that Seven Stars B.V., part of its Circle8 Group platform, secured a four-year framework agreement with the Dutch Vehicle Authority to supply specialized ICT professionals, reinforcing its presenc...
Business Operations and StrategyExecutive/Board ChangesLegal Proceedings
Atlantic International Challenges Creditor Default Claims in Court
Negative
Apr 3, 2026
On March 30, 2026, SPP Credit Advisors issued default notices to Atlantic International and its Lyneer subsidiaries under both an April 29, 2025 term loan agreement and a June 18, 2024 bridge loan, alleging breaches of financial and non-financial ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.